Kurtzman CP, Fell JW (1998) The yeasts: a taxonomic study, 4th edn. Elsevier Science BV, Amsterdam, The Netherlands
Calderone RA (2002) Candida and candidiasis. ASM Press, Washington, DC
Chibana H, Oka N, Nakayama H, Aoyama T, Magee BB, Magee PT, Mikami Y (2005) Sequence finishing and gene mapping for Candida albicans chromosome 7 and syntenic analysis against the Saccharomyces cerevisiae genome. Genetics 170:1525–1537
Odds FC (1988) Candida and candidosis, 3rd edn. Balliere Tindall, London
Larriba G, Rubio Coque JJ, Ciudad A, Andaluz E (2000) Candida albicans molecular biology reaches its maturity. Int Microbiol 3:247–252
Sudbery P, Gow N, Berman J (2004) The distinct morphogenic states of Candida albicans. Trends Microbiol 12:317–324
Parker JC Jr, McCloskey JJ, Knauer KA (1976) Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol 65:991–1000
Pfaller MA (1996) Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22:S89–S94
Ramage G, Saville SP, Thomas DP, López-Ribot JL (2005) Candida biofilms: an update. Eukaryot Cell 4:633–638
Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42:4419–4431
Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163
Pendrak ML, Yan SS, Roberts DD (2004) Sensing the host environment: recognition of hemoglobin by the pathogenic yeast Candida albicans. Arch Biochem Biophys 426:148–156
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317
Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J (2002) The direct cost and incidence of systemic fungal infections. Value Health 5:26–34
Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519–1527
Todischini GT (1997) Treatment of candidiasis: a perspective on recent advances and future challenges. Int J Infect Dis 1(Suppl):S37–S41
Boos C, Kujath P, Bruch HP (2005) Intra-abdominal mycoses. Mycoses 48(Suppl 1):22–26
Fischer L, Sterneck M (2005) Invasive fungal infections in patients after liver transplantation. Mycoses 48(Suppl 1):27–35
Yap HY, Kwok KM, Gomersall CD, Fung SC, Lam TC, Leung PN, Hui M, Joynt GM (2009) Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong. Hong Kong Med J 15:255–261
Yang CW, Barkham TMS, Chan FY, Wang Y (2003) Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 41:472–474
Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, Hsieh KS, Ho M, Lo HJ (2004) Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 48:33–37
Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S; The Japanese Invasive Mycoses Surveillance Study Group (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemoth 53:283–289
Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N (2004) Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999–2002. J Med Assoc Thai 87:92–99
Ng KP, Saw TL, Na SL, Soo-Hoo TS (2001) Systemic Candida infection in University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Mycopathologia 149:141–146
Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9:327–335
Berman J, Sudbery PE (2002) Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3:918–930
Kumamoto CA, Vinces MD (2005) Alternative Candida albicans lifestyles: growth on surfaces. Annu Rev Microbiol 59:113–133
Gaur NK, Klotz SA, Henderson RL (1999) Overexpression of the Candida albicans ALA1 gene in Saccharomyces cerevisiae results in aggregation following attachment of yeast cells to extracellular matrix proteins, adherence properties similar to those of Candida albicans. Infect Immun 67:6040–6047
Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP (1998) Cell wall and secreted proteins of Candida albicans: Identification, function, and expression. Microbiol Mol Biol Rev 62:130–180
Gow NA (1997) Germ tube growth of Candida albicans. Curr Top Med Mycol 8:43–55
Brown DH Jr, Giusani AD, Chen X, Kumamoto CA (1999) Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene. Mol Microbiol 34:651–662
Fukazawa Y, Kagaya K (1997) Molecular bases of adhesion of Candida albicans. J Med Vet Mycol 35:87–99
Ghannoum MA, Burns GR, Abu Elteen K, Radwan SS (1986) Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells. Infect Immun 54:189–193
Fu Y, Rieg G, Fonzi WA, Belanger PH, Edwards JE Jr, Filler SG (1998) Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells. Infect Immun 66:1783–1786
Staab JF, Bradway SD, Fidel PL, Sundstrom P (1999) Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535–1538
Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122–143
Monod M, Hube B, Hess D, Sanglard D (1998) Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144:2731–2737
Crampin H, Finley K, Gerami-Nejad M, Court H, Gale C, Berman J, Sudbery P (2005) Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J Cell Sci 118:2935–2947
Hazan I, Sepulveda-Becerra M, Liu H (2002) Hyphal elongation is regulated independently of cell cycle in Candida albicans. Mol Biol Cell 13:134–145
Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053–1060
Kruppa M (2009) Quorum sensing and Candida albicans. Mycoses 52:1–10
Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink G (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90:939–949
Stoldt VR, Sonneborn A, Leuker CE, Ernst JF (1997) Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16:1982–1991
Lane S, Birse C, Zhou S, Matson R, Liu H (2001) DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J Biol Chem 276:48988–48996
El Barkani A, Kurzai O, Fonzi WA, Ramon A, Porta A, Frosch M, Mühlschlegel FA (2000) Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans. Mol Cell Biol 20:4635–4647
Braun BR, Johnson AD (1997) Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105–109
Braun BR, Johnson AD (2000) TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155:57–67
Braun BR, Kadosh D, Johnson AD (2001) NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. EMBO J 20:4753–4761
Kadosh D, Johnson AD (2005) Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol Cell 16:2903–2912
Murad AMA, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, d’Enfert C, Gaillardin C, Odds FC, Brown AJP (2001) NRG1 represses yeast–hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20:4742–4752
Ishii N, Yamamoto M, Yoshihara F, Arisawa M, Aoki Y (1997) Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicans. Microbiology 143:429–435
Feng Q, Summers E, Guo B, Fink G (1999) Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol 181:6339–6346
Brown AJP (2002) Morphogenetic signaling pathways in Candida albicans. In: Calderone RA (ed) Candida and candidiasis. ASM Press, Washington, DC, pp 95–106
Zheng X, Wang Y, Wang Y (2004) Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 23:1845–1856
Kobayashi SD, Cutler JE (1998) Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol 6:92–94
Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385–5394
Leonhardt A, Renvert S, Dahlén G (1999) Microbial findings at failing implants. Clin Oral Implants Res 10:339–345
Baillie GS, Douglas LJ (1999) Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48:671–679
Ramage G, Vandewalle K, Wickes BL, López-Ribot JL (2001) Characteristics of biofilm formation by Candida albicans. Rev Iberoem Micol 18:163–170
Kulkarni RV, Nickerson KW (1981) Nutritional control of dimorphism in Ceratocystis ulmi. Exp Mycol 5:148–154
Lingappa BT, Prasad M, Lingappa Y, Hunt DF, Biemann K (1969) Phenethyl alcohol and tryptophol: autoantibiotics produced by the fungus Candida albicans. Science 163:192–194
Hazen KC, Cutler JE (1979) Autoregulation of germ tube formation by Candida albicans. Infect Immun 24:661–666
Hazen KC, Cutler JE (1983) Isolation and purification of morphogenic autoregulatory substance produced by Candida albicans. J Biochem 94:777–783
Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R, Dussault P, Nickerson KW (2001) Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67:2982–2992
Chen H, Fujita M, Feng Q, Clardy J, Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA 101:5048–5052
Nickerson KW, Atkin AL, Hornby JM (2006) Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol 72:3805–3813
Hogan DA, Vik A, Kolter R (2004) A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54:1212–1223
Lim CSY, Wong WF, Rosli R, Ng KP, Seow HF, Chong PP (2009) 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR2 expression in C. albicans. J Basic Microbiol 49:579–583
Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, Edwards JE Jr, Filler SG (2005) Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7:499–510
Hornby JM, Nickerson KW (2004) Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob Agents Chemother 48:2305–2307
Navarathna DHMLP, Hornby JM, Hoerrmann N, Parkhurst AM, Duhamel GE, Nickerson KW (2005) Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J Antimicrob Chemother 56:1156–1159
Navarathna DHMLP, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW (2007) Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun 75:1609–1618
Navarathna DHMLP, Nickerson KW, Duhamel GE, Jerrels TR, Petro TM (2007) Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model. Infect Immun 75:4006–4011
Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA (2008) Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 67:47–62
Rocha CRC, Schröppel K, Harcus D, Marcil A, Dignard D, Taylor BN, Thomas DY, Whiteway M, Leberer E (2001) Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Mol Biol Cell 12:3631–3643
Cho T, Hamatake H, Kaminishi H, Hagihara Y, Watanabe K (1992) The relationship between cyclic adenosine 3′,5′-monophosphate and morphology in exponential phase Candida albicans. J Med Vet Mycol 30:35–42
Maydan M, Eskandarian M, Serneels J, Tournu H, Van Dijck P (2005) Methionine-induced morphogenesis in Candida albicans is dependent on the methionine permease Mup1 and the G-protein coupled receptor Gpr1. FEBS advanced lecture course on human fungal pathogens, 1st ed. Molecular Microbiology and Biotechnology Section, La Colle sur Loup, France, miscellaneous.
Castilla R, Passeron S, Cantore ML (1998) N-acetyl-D-glucosamine induces germination in Candida albicans through a mechanism sensitive to inhibitors of cAMP-dependent protein kinase. Cell Signal 10:713–719
Leberer E, Harcus D, Dignard D, Johnson L, Ushinsky S, Thomas DY, Schröppel K (2001) Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans. Mol Microbiol 42:673–687
Hube B (2004) From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 7:336–341
Odds FC (1994) Candida and candidosis. A review and bibliography. Balliere Tindall, London
Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC, Hube B (2005) Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56:397–415
Grubb SEW, Murdoch C, Sudbery PE, Saville SP, Lopez-Ribot JL, Thornhill MH (2008) Candida albicans–endothelial cell interactions: A key step in the pathogenesis of systemic candidiasis. Infect Immun 76:4370–4377
Orozco AS, Zhou X, Filler SG (2000) Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun 68:1134–1141
Filler SG (2006) Candida–host cell receptor–ligand interactions. Curr Opin Microbiol 9:333–339
Filler SG, Sheppard DC (2006) Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2:e129. doi:
Nadir E, Kaufshtein M (2005) Images in clinical medicine. Candida albicans in a peripheral-blood smear. N Engl J Med 353:e9
Villar CC, Kashleva H, Mitchell AP, Dongari-Bagtzoglou A (2005) Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 73:4588–4595
Phan QT, Belanger PH, Filler SG (2000) Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68:3485–3490
Barker KS, Park H, Phan QT, Xu L, Homayouni R, Rogers PD, Filler SG (2008) Transcriptome profile of the vascular endothelial cell response to Candida albicans. J Infect Dis 198:193–202
Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, Greer BT, Chanock S, Lyman CA, Walsh TJ (2005) Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun 73:3714–3724
Barker KS, Liu T, Rogers PD (2005) Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression. J Infect Dis 192:901–912
Huang C, Levitz SM (2000) Stimulation of macrophage inflammatory protein-1α, macrophage inflammatory protein-1β, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection. J Infect Dis 181:791–794
Aybay C, Imir T (1996) Tumor necrosis factor (TNF) induction from monocyte/macrophages by Candida species. Immunobiology 196:363–374
Trinchieri G (1995) The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells. Ciba Found Symp 195:203–214
Xiong J, Kang K, Liu L, Yoshida Y, Cooper KD, Ghannoum MA (2000) Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production. Infect Immun 68:2464–2469
Fidel PL Jr (2002) Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 40:359–375
Fidel PL Jr (2002) The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models. Int Rev Immunol 21:515–548
van der Graaf CAA, Netea MG, Verschueren I, van der Meer JWM, Kullberg BJ (2005) Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 73:7458–7464
Vazquez-Torres A, Jones-Carson J, Wagner RD, Warner T, Balish E (1999) Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun 67:670–674
Evans ZA (1981) Tissue responses to the blastospores and hyphae of Candida albicans in the mouse. J Med Microbiol 14:307–319
Grubb SEW, Murdoch C, Sudbery PE, Saville SP, Lopez-Ribot JL, Thornhill MH (2009) Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infect Immun 77:3872–3878
Bendel CM, Hess DJ, Garni RM, Henry-Stanley M, Wells CL (2003) Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med 31:501–507
Chen CG, Yang YL, Cheng HH, Su CL, Huang SF, Chen CT, Liu YT, Su IJ, Lo HJ (2006) Non-lethal Candida albicans cph1/cph1 efg1/efg1 transcription factor mutant establishing restricted zone of infection in a mouse model of systemic infection. Int J Immunopathol Pharmacol 19:561–565
Spellberg BJ, Johnston DA, Phan QT, Edwards JE Jr, French SW, Ibrahim AS, Filler SG (2003) Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect Immun 71:5756–5764
White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA (2007) Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog 3(12):e184. doi:
Evans ZA, Mardon DN (1977) Organ localization in mice challenged with a typical Candida albicans strain and a pseudohyphal variant. Proc Soc Exp Biol Med 155:234–238
MacCallum DM, Odds FC (2005) Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48:151–161
Rotrosen D, Edwards JE Jr, Gibson TR, Moore JC, Cohen AH, Green I (1985) Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis 152:1264–1274
Saisho Y, Morimoto A, Umeda T (1997) Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal Biochem 252:89–95
Voziyan PA, Haug JS, Melnykovych G (1995) Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol-induced apoptotic cell death. Biochem Biophys Res Commun 212:479–486
Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O (2004) Iron-source preference of Staphylococcus aureus infections. Science 305:1626–1628
Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, Tiraboschi N, Nagy E, Gibbs DL; The Global Antifungal Surveillance Group (2005) Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 43:5848–5859